tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Generation Bio price target raised to $10 from $9 at Canaccord

Canaccord raised the firm’s price target on Generation Bio (GBIO) to $10 from $9 and keeps a Buy rating on the shares. The firm said the company update included 2 key announcements. First, it announced new NHP data that shows siRNA delivery to T cells via the company’s proprietary ctLNP platform; likely the first dataset of its kind. And also noted that it has developed siRNA candidates targeting LAT1 and VAV1, known targets in the autoimmune space.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1